Prior authorization required
Does Mcs Advantage, INC. require prior authorization for Jakafi?
Mcs Advantage, INC. requires prior authorization for Jakafi on every Medicare Part D plan of theirs that covers it.
Every plan from this payer that covers the drug requires authorization before it is dispensed.
By product strength
| RxNorm product | Plans covering | Require prior auth | Status |
|---|---|---|---|
| ruxolitinib 10 MG Oral Tablet [Jakafi]1193337 | 20 / 20 | 20 | Prior authorization required |
| ruxolitinib 5 MG Oral Tablet [Jakafi]1193341 | 20 / 20 | 20 | Prior authorization required |
| ruxolitinib 15 MG Oral Tablet [Jakafi]1193345 | 20 / 20 | 20 | Prior authorization required |
| ruxolitinib 20 MG Oral Tablet [Jakafi]1193349 | 20 / 20 | 20 | Prior authorization required |
| ruxolitinib 25 MG Oral Tablet [Jakafi]1193353 | 20 / 20 | 20 | Prior authorization required |
Product names come from RxNorm (U.S. National Library of Medicine).
Source
Monthly Prescription Drug Plan Formulary and Pharmacy Network Information — Basic Drugs Formulary File- Effective
- 2026-06-30
- Retrieved
- 2026-07-19
- SHA-256
- e626e6bcda1aa6a0071e6f0df6bafe686ae41842cdf0a9feffdc649b6d3ff3ae
We publish the hash of the exact file we ingested so any answer can be audited against the bytes CMS served that day.
Jakafi at other payers
Administrative information only. Benefily reports what a payer has published in its own prior-authorization policy as of the effective date shown. It is not medical advice, not a coverage or payment guarantee, and not an authorization. Requirements vary by plan, place of service and member benefits — always verify with the payer before rendering service.